Join Us for May’s Brown Bag Webinar – Narcolepsy Diagnostic Journey

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024

Harmony Biosciences Announces Exclusive Agreement To Develop And Commercialize TPM-1116, A Highly Potent And Selective Oral Orexin-2 Receptor Agonist

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

Join Us for April’s Brown Bag Webinar – Canada: Narcolepsy Medications & Access to Care

WUN Board Member Kelsey Biddle Talks about Narcolepsy in “The Harvard Gazette”

Zevra Announces Phase 2 IH Clinical Trial Results – Wake Up Narcolepsy Community Update

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

Celebrating Women in Wake Up Narcolepsy’s Journey – Women’s History Month 2024

Sleep Awareness Week 2024 Wake Up Narcolepsy Schedule